Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$5.01 USD
+0.46 (10.11%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.99 -0.02 (-0.40%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Sutro Biopharma, Inc. [STRO]
Reports for Purchase
Showing records 1 - 20 ( 164 total )
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Loving Luvelta?s Progress Across Diverse Oncogenic Indications: Reit. Buy and $12 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
STRO Sells a Three, Keeps Luvelta for the Finals
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
A Growing FolRa-Targeting ADC Franchise the Game; Reit. Buy and Lowering Our PT to $12
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
STRO''s Luvelta Getting Ready for the Season
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Luvelta Forum Highlights its Future Potential and Attractive Positioning
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Luvelta?s Footprint Continues to be Undervalued; Reit. Buy and $16 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A